Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News EyePoint Pharmaceuticals Inc EYPT

Healthcare
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the business of developing and commercializing ophthalmic products for the treatment of eye diseases. The Company's pipeline leverages its Durasert technology (Durasert) for sustained intraocular drug delivery, including delivery of EYP-1901, is an investigational sustained delivery treatment... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:EYPT)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire 3 days ago

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire November 7, 2024

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

GlobeNewswire November 4, 2024

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares

GlobeNewswire October 31, 2024

EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering

GlobeNewswire October 29, 2024

EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock

GlobeNewswire October 28, 2024

EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU(TM) for Diabetic Macular Edema

GlobeNewswire October 28, 2024

EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration

GlobeNewswire October 24, 2024

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire October 16, 2024
View More News ››

Opinion & Analysis (NDAQ:EYPT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:EYPT)

EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of

Just In: $EYPT EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 10/28EyePoint Pharmaceuticals...
whytestocks - October 28, 2024

Spirit Airlines Posts Weak Results, Joins Integra LifeScienc

JUST IN: $EYPT Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday...
whytestocks - May 6, 2024

EyePoint Pharmaceuticals to Present at the Guggenheim Health

Breaking News: $EYPT EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceWATERTOWN...
whytestocks - January 31, 2024

I "SEE" nothing but $$$$$$$ Coming our way!

Here's to LOOKING up!!
PumperGuy - January 22, 2024

EYEPOINT PHARMACEUTICALS: A BOON FOR EYE DISEASE PATIENTS

$EYPT Excited to share an article about EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) - the Company develops and commercializes...
AviseAnalytics - January 5, 2024
View more Bullboard ››

Nicola Mining Inc

Nicola Mining Inc

Nicola Mining Inc. is a Canada-based junior mining company. The Company maintains a 100% owned mill and tailings facility ...
View More »